Ageing - Pipeline Review, H2 2016

  • ID: 3946440
  • Drug Pipelines
  • 53 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Mapreg S.A.S.
  • Saje Pharma, LLC
  • Theravasc, Inc.
  • MORE
Ageing - Pipeline Review, H2 2016

Summary

Our latest Pharmaceutical and Healthcare disease pipeline guide Ageing - Pipeline Review, H2 2016, provides an overview of the Ageing (Metabolic Disorders) pipeline landscape.

Ageing is the accumulation of changes in a person over time. Symptoms include stooped posture, constipation, and increased susceptibility to infection, risk of heat stroke or hypothermia, decrease in visual acuity, wrinkling and sagging skin, and diminished peripheral vision.

Report Highlights

Our Pharmaceutical and Healthcare latest pipeline guide Ageing - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Ageing (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Ageing (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ageing and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 5 and 3 respectively for Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively for Ageing.

Ageing (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Ageing (Metabolic Disorders).
- The pipeline guide reviews pipeline therapeutics for Ageing (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Ageing (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Ageing (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Ageing (Metabolic Disorders)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Ageing (Metabolic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Ageing (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Mapreg S.A.S.
  • Saje Pharma, LLC
  • Theravasc, Inc.
  • MORE
List of Tables

List of Figures

Introduction

Report Coverage

Ageing Overview

Therapeutics Development

Pipeline Products for Ageing - Overview

Pipeline Products for Ageing - Comparative Analysis

Ageing - Therapeutics under Development by Companies

Ageing - Therapeutics under Investigation by Universities/Institutes

Ageing - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Ageing - Products under Development by Companies

Ageing - Products under Investigation by Universities/Institutes

Ageing - Companies Involved in Therapeutics Development

Generon (Shanghai) Corporation Ltd.

Mapreg S.A.S.

RepliCel Life Sciences, Inc.

RXi Pharmaceuticals Corporation

Saje Pharma, LLC

Theravasc, Inc.

Ageing - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

AGS-499 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

BQ-A - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Drugs for Ageing - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

F-899 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

MAP-46 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

MG-29 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

MMP-26051 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

MMP-26052 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

RCS-01 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

sirolimus - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

sodium nitrite SR - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SPL-891.1 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

TM-5441 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Ageing - Dormant Projects

Ageing - Product Development Milestones

Featured News & Press Releases

Apr 20, 2016: RepliCel Life Sciences Finishes Enrolment for its Skin Rejuvenation Clinical Trial

Dec 17, 2015: RepliCel Announces Completion of First Injections in Clinical Trial of RCS-01 for Skin Aging and UV-Damaged Skin

Sep 15, 2015: RepliCel Life Sciences Announces Initiation of Clinical Site and Participant Recruitment for European Skin Aging Study

Jul 21, 2015: RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial

Feb 23, 2015: RepliCel Submits Clinical Trial Application for its Dermatological Clinical Trial

Oct 09, 2014: RepliCel to Present Commercial and Clinical Update on RCS-01 at BioJapan 2014 World Business Forum

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Ageing, H2 2016

Number of Products under Development for Ageing - Comparative Analysis, H2 2016

Number of Products under Development by Companies, H2 2016

Number of Products under Investigation by Universities/Institutes, H2 2016

Comparative Analysis by Clinical Stage Development, H2 2016

Comparative Analysis by Early Stage Development, H2 2016

Products under Development by Companies, H2 2016

Products under Investigation by Universities/Institutes, H2 2016

Ageing - Pipeline by Generon (Shanghai) Corporation Ltd., H2 2016

Ageing - Pipeline by Mapreg S.A.S., H2 2016

Ageing - Pipeline by RepliCel Life Sciences, Inc., H2 2016

Ageing - Pipeline by RXi Pharmaceuticals Corporation, H2 2016

Ageing - Pipeline by Saje Pharma, LLC, H2 2016

Ageing - Pipeline by Theravasc, Inc., H2 2016

Assessment by Monotherapy Products, H2 2016

Number of Products by Stage and Target, H2 2016

Number of Products by Stage and Mechanism of Action, H2 2016

Number of Products by Stage and Route of Administration, H2 2016

Number of Products by Stage and Molecule Type, H2 2016

Ageing - Dormant Projects, H2 2016

List of Figures

Number of Products under Development for Ageing, H2 2016

Number of Products under Development for Ageing - Comparative Analysis, H2 2016

Number of Products under Development by Companies, H2 2016

Number of Products under Investigation by Universities/Institutes, H2 2016

Comparative Analysis by Clinical Stage Development, H2 2016

Comparative Analysis by Early Stage Products, H2 2016

Assessment by Monotherapy Products, H2 2016

Number of Products by Targets, H2 2016

Number of Products by Stage and Targets, H2 2016

Number of Products by Mechanism of Actions, H2 2016

Number of Products by Stage and Mechanism of Actions, H2 2016

Number of Products by Routes of Administration, H2 2016

Number of Products by Stage and Routes of Administration, H2 2016

Number of Products by Molecule Types, H2 2016

Number of Products by Stage and Molecule Types, H2 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Generon (Shanghai) Corporation Ltd.
Mapreg S.A.S.
RepliCel Life Sciences, Inc.
RXi Pharmaceuticals Corporation
Saje Pharma, LLC
Theravasc, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll